Successful treatment of severe subacute cutaneous lupus erythematosus with rituximab in an adolescent.

Dodds, Melissa; Hobday, Patricia; Schultz, Brittney; Maguiness, Sheilagh

Dodds, Melissa; Hobday, Patricia; Schultz, Brittney; Maguiness, Sheilagh.

Afiliação

Dodds M; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.
Hobday P; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
Schultz B; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.
Maguiness S; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.

Pediatr Dermatol ; 35(3): e189-e190, 2018 May.

Article em En | MEDLINE | ID: mdl-29570834

ABSTRACT

ABSTRACT

Subacute cutaneous lupus erythematosus is rare in children. Most patients respond well to conventional therapy with prednisone, hydroxychloroquine, or both. Other case reports and small series have reported successful clearance with rituximab in adults. We report an adolescent who obtained remission with rituximab after failing conventional therapy.

Assuntos

Fatores Imunológicos/uso terapêutico; Lúpus Eritematoso Cutâneo/tratamento farmacológico; Rituximab/uso terapêutico; Adolescente; Humanos; Lúpus Eritematoso Cutâneo/diagnóstico; Masculino; Pele/patologia; Resultado do Tratamento

Palavras-chave

collagen vascular disorder; inflammatory disorders; systemic; therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Cutâneo / Rituximab / Fatores Imunológicos Tipo de estudo: Diagnostic_studies Limite: Adolescent / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google